Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies
- Publikationstyp:
- Zeitschriftenaufsatz
- Metadaten:
-
- Autoren
- Akbar Hasanzadeh
- Masoomeh Alamdaran
- Sepideh Ahmadi
- Helena Nourizadeh
- Mohammad Aref Bagherzadeh
- Mirza Ali Mofazzal Jahromi
- Perikles Simon
- Mahdi Karimi
- Michael R Hamblin
- Autoren-URL
- https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=fis-test-1&SrcAuth=WosAPI&KeyUT=WOS:000685045200006&DestLinkType=FullRecord&DestApp=WOS_CPL
- DOI
- 10.1016/j.jconrel.2021.06.036
- eISSN
- 1873-4995
- Externe Identifier
- Clarivate Analytics Document Solution ID: UA3EN
- PubMed Identifier: 34175366
- ISSN
- 0168-3659
- Zeitschrift
- JOURNAL OF CONTROLLED RELEASE
- Schlüsselwörter
- Nanotechnology
- Nanovaccine
- Diagnosis
- SARS-CoV-2
- COVID-19
- Paginierung
- 354 - 374
- Datum der Veröffentlichung
- 2021
- Status
- Published
- Titel
- Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies
- Sub types
- Review
- Ausgabe der Zeitschrift
- 336
Datenquelle: Web of Science (Lite)
- Andere Metadatenquellen:
-
- Autoren
- Akbar Hasanzadeh
- Masoomeh Alamdaran
- Sepideh Ahmadi
- Helena Nourizadeh
- Mohammad Aref Bagherzadeh
- Mirza Ali Mofazzal Jahromi
- Perikles Simon
- Mahdi Karimi
- Michael R Hamblin
- DOI
- 10.1016/j.jconrel.2021.06.036
- ISSN
- 0168-3659
- Zeitschrift
- Journal of Controlled Release
- Sprache
- en
- Paginierung
- 354 - 374
- Datum der Veröffentlichung
- 2021
- Status
- Published
- Herausgeber
- Elsevier BV
- Herausgeber URL
- http://dx.doi.org/10.1016/j.jconrel.2021.06.036
- Datum der Datenerfassung
- 2023
- Titel
- Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies
- Ausgabe der Zeitschrift
- 336
Datenquelle: Crossref
- Abstract
- The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020 soon led to the global pandemic of Coronavirus Disease 2019 (COVID-19). Since then, the clinical and scientific communities have been closely collaborating to develop effective strategies for controlling the ongoing pandemic. The game-changing fields of recent years, nanotechnology and nanomedicine have the potential to not only design new approaches, but also to improve existing methods for the fight against COVID-19. Nanomaterials can be used in the development of highly efficient, reusable personal protective equipment, and antiviral nano-coatings in public settings could prevent the spread of SARS-CoV-2. Smart nanocarriers have accelerated the design of several therapeutic, prophylactic, or immune-mediated approaches against COVID-19. Some nanovaccines have even entered Phase IΙ/IIΙ clinical trials. Several rapid and cost-effective COVID-19 diagnostic techniques have also been devised based on nanobiosensors, lab-on-a-chip systems, or nanopore technology. Here, we provide an overview of the emerging role of nanotechnology in the prevention, diagnosis, and treatment of COVID-19.
- Addresses
- Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran; Department of Medical Nanotechnology, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Autoren
- Akbar Hasanzadeh
- Masoomeh Alamdaran
- Sepideh Ahmadi
- Helena Nourizadeh
- Mohammad Aref Bagherzadeh
- Mirza Ali Mofazzal Jahromi
- Perikles Simon
- Mahdi Karimi
- Michael R Hamblin
- DOI
- 10.1016/j.jconrel.2021.06.036
- eISSN
- 1873-4995
- Externe Identifier
- PubMed Identifier: 34175366
- PubMed Central ID: PMC8226031
- Funding acknowledgements
- Iran's National Elites Foundation:
- Iran University of Medical Sciences: 97-3-75-13318
- Open access
- true
- ISSN
- 0168-3659
- Zeitschrift
- Journal of controlled release : official journal of the Controlled Release Society
- Schlüsselwörter
- Humans
- Immunization
- Nanotechnology
- Pandemics
- COVID-19
- SARS-CoV-2
- Sprache
- eng
- Medium
- Print-Electronic
- Online publication date
- 2021
- Open access status
- Open Access
- Paginierung
- 354 - 374
- Datum der Veröffentlichung
- 2021
- Status
- Published
- Datum der Datenerfassung
- 2021
- Titel
- Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.
- Sub types
- Research Support, Non-U.S. Gov't
- review-article
- Review
- Journal Article
- Ausgabe der Zeitschrift
- 336
Files
https://europepmc.org/articles/PMC8226031?pdf=render
Datenquelle: Europe PubMed Central
- Abstract
- The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020 soon led to the global pandemic of Coronavirus Disease 2019 (COVID-19). Since then, the clinical and scientific communities have been closely collaborating to develop effective strategies for controlling the ongoing pandemic. The game-changing fields of recent years, nanotechnology and nanomedicine have the potential to not only design new approaches, but also to improve existing methods for the fight against COVID-19. Nanomaterials can be used in the development of highly efficient, reusable personal protective equipment, and antiviral nano-coatings in public settings could prevent the spread of SARS-CoV-2. Smart nanocarriers have accelerated the design of several therapeutic, prophylactic, or immune-mediated approaches against COVID-19. Some nanovaccines have even entered Phase IΙ/IIΙ clinical trials. Several rapid and cost-effective COVID-19 diagnostic techniques have also been devised based on nanobiosensors, lab-on-a-chip systems, or nanopore technology. Here, we provide an overview of the emerging role of nanotechnology in the prevention, diagnosis, and treatment of COVID-19.
- Date of acceptance
- 2021
- Autoren
- Akbar Hasanzadeh
- Masoomeh Alamdaran
- Sepideh Ahmadi
- Helena Nourizadeh
- Mohammad Aref Bagherzadeh
- Mirza Ali Mofazzal Jahromi
- Perikles Simon
- Mahdi Karimi
- Michael R Hamblin
- Autoren-URL
- https://www.ncbi.nlm.nih.gov/pubmed/34175366
- DOI
- 10.1016/j.jconrel.2021.06.036
- eISSN
- 1873-4995
- Externe Identifier
- PubMed Central ID: PMC8226031
- Zeitschrift
- J Control Release
- Schlüsselwörter
- COVID-19
- Diagnosis
- Nanotechnology
- Nanovaccine
- SARS-CoV-2
- COVID-19
- Humans
- Immunization
- Nanotechnology
- Pandemics
- SARS-CoV-2
- Sprache
- eng
- Country
- Netherlands
- Paginierung
- 354 - 374
- PII
- S0168-3659(21)00334-5
- Datum der Veröffentlichung
- 2021
- Status
- Published
- Datum, an dem der Datensatz öffentlich gemacht wurde
- 2021
- Titel
- Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.
- Sub types
- Journal Article
- Research Support, Non-U.S. Gov't
- Review
- Ausgabe der Zeitschrift
- 336
Datenquelle: PubMed
- Beziehungen:
- Eigentum von